BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Plexigen
Plexigen developed a proprietary 3-D biochip designed to significantly enhance the capacity, efficiency, accuracy and automation of gene screening.
Plexigen
Cary, NC
